Fingerprint
Dive into the research topics of 'Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS
Ola Landgren*, Ajai Chari, Yael C. Cohen, Andrew Spencer, Peter M. Voorhees, Irwindeep Sandhu, Matthew W. Jenner, Dean Smith, Michele Cavo, Niels W.C.J. van de Donk, Meral Beksac, Philippe Moreau, Hartmut Goldschmidt, Diego Vieyra, Linlin Sha, Liang Li, Els Rousseau, Robyn Dennis, Robin Carson, Craig C. Hofmeister
*Corresponding author for this work
- University of Miami
- Icahn School of Medicine at Mount Sinai
- Monash University
- Wake Forest University
- University of Alberta
- University Hospital Southampton NHS Foundation Trust
- University of Nottingham
- University of Bologna
- Academic Medical Centre
- Ankara University
- CHU de Nantes
- Heidelberg University
- Johnson & Johnson
- Emory University
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations